Sonya Del Tredici and John Keenan

Addiction Medicine Journal Club

Sonya Del Tredici and John Keenan

  • 71. Buprenorphine and Dental Problems

71. Buprenorphine and Dental Problems

Monday 2nd March 2026

Explore the link between buprenorphine and dental issues in addiction treatment with expert insights from Dr. Keenan and Dr. Del Tredici.
34 minutes
Informative
Educational
Engaging
Honest
Thought-provoking

About this podcast

Addiction Medicine Journal Club
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
85 (View all)
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Buprenorphine's Dental Dilemma: A Surprising Side Effect?

Episode Overview

  • Buprenorphine may contribute to dental problems, but benefits outweigh risks.
  • Consider counselling patients on dental hygiene when prescribing buprenorphine.
  • Over-the-counter naltrexone could increase access for alcohol use disorder treatment.
  • The FDA warns of potential oral health risks with transmucosal buprenorphine.
  • Public health policies impact addiction treatment strategies.
"The benefits of buprenorphine are huge... I definitely would recommend it for opiate use disorder."
Curious about how others navigate their sobriety journey? Episode 71 of the Addiction Medicine Journal Club dives into the unexpected dental issues linked to buprenorphine, a medication often used to treat opioid use disorder. Dr. John Keenan and Dr. Sonya Del Tredici explore the latest research on this topic, discussing a study that examines whether buprenorphine is the real culprit behind dental problems in patients with opioid use disorder.
The hosts provide an engaging discussion on the challenges of interpreting medical data and its real-world implications. Additionally, they touch upon the intriguing proposal of making naltrexone available over-the-counter to address alcohol use disorder, sparking a debate on accessibility and safety. With light-hearted banter and expert insights, this episode offers a blend of humour and serious discussion about the intersection of addiction treatment and dental health.
By the end, you'll be pondering if buprenorphine's benefits outweigh its potential risks and whether easier access to medications like naltrexone could change the landscape of addiction treatment. Tune in to find out how these discussions could impact your practice or personal journey.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2026 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.